173 related articles for article (PubMed ID: 19420170)
41. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.
Tenover FC; Swenson JM; O'Hara CM; Stocker SA
J Clin Microbiol; 1995 Jun; 33(6):1524-7. PubMed ID: 7650179
[TBL] [Abstract][Full Text] [Related]
42. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada.
Webster D; Rennie RP; Brosnikoff CL; Chui L; Brown C
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):177-81. PubMed ID: 16938420
[TBL] [Abstract][Full Text] [Related]
43. Detection of vancomycin resistant Staphylococcus aureus: a comparative study of three different phenotypic screening methods.
Bhateja P; Mathur T; Pandya M; Fatma T; Rattan A
Indian J Med Microbiol; 2005 Jan; 23(1):52-5. PubMed ID: 15928424
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods.
Mohammed MJ; Marston CK; Popovic T; Weyant RS; Tenover FC
J Clin Microbiol; 2002 Jun; 40(6):1902-7. PubMed ID: 12037041
[TBL] [Abstract][Full Text] [Related]
45. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
Jones RN; Barry AL; Gardiner RV; Packer RR
Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
[TBL] [Abstract][Full Text] [Related]
46. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.
Ike Y; Arakawa Y; Ma X; Tatewaki K; Nagasawa M; Tomita H; Tanimoto K; Fujimoto S
J Clin Microbiol; 2001 Dec; 39(12):4445-51. PubMed ID: 11724859
[TBL] [Abstract][Full Text] [Related]
47. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
[TBL] [Abstract][Full Text] [Related]
48. Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.
Aeschlimann JR; Hershberger E; Rybak MJ
Antimicrob Agents Chemother; 1999 Aug; 43(8):1914-8. PubMed ID: 10428912
[TBL] [Abstract][Full Text] [Related]
49. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
Jevitt LA; Thorne GM; Traczewski MM; Jones RN; McGowan JE; Tenover FC; Brown SD
J Clin Microbiol; 2006 Sep; 44(9):3098-104. PubMed ID: 16954233
[TBL] [Abstract][Full Text] [Related]
50. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the Vitek GPS-TB card with disk diffusion testing for predicting the susceptibility of enterococci to vancomycin.
Williams-Bouyer N; Reisner BS; Woodmansee CE; Falk PS; Mayhall CG
Arch Pathol Lab Med; 1999 Jul; 123(7):622-5. PubMed ID: 10388920
[TBL] [Abstract][Full Text] [Related]
52. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
Kusuma CM; Kokai-Kun JF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
[TBL] [Abstract][Full Text] [Related]
53. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
Bland CM; Porr WH; Davis KA; Mansell KB
South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
[TBL] [Abstract][Full Text] [Related]
55. BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.
Junkins AD; Lockhart SR; Heilmann KP; Dohrn CL; Von Stein DL; Winokur PL; Doern GV; Richter SS
J Clin Microbiol; 2009 Sep; 47(9):2879-82. PubMed ID: 19625483
[TBL] [Abstract][Full Text] [Related]
56. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.
Wang G; Hindler JF; Ward KW; Bruckner DA
J Clin Microbiol; 2006 Nov; 44(11):3883-6. PubMed ID: 16957043
[TBL] [Abstract][Full Text] [Related]
57. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
Kim MN; Hwang SH; Pyo YJ; Mun HM; Pai CH
J Clin Microbiol; 2002 Apr; 40(4):1376-80. PubMed ID: 11923359
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Sader HS; Becker HK; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
[TBL] [Abstract][Full Text] [Related]
59. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
Bhateja P; Purnapatre K; Dube S; Fatma T; Rattan A
Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
[TBL] [Abstract][Full Text] [Related]
60. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
